NEXGEL, INC.

NXGL

NEXGEL, INC.

NXGL

Insider Sentiment (TTM):

Last Purchase:2024-11-20Last Sale:2026-06-23Shares Purchased (TTM):0Shares Sold (TTM):47,272

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:408,142Shares Outstanding:8,204,205Institutional Ownership Pct.:4.97%

Earnings Market Reaction:

Filing Date:2026-08-17Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash	0	0	0	1	1	1	2	1	1	2	3	3
Restricted Cash Current	1	2	1	1	-	-	-	-	-	-	-	-
Accounts Receivable Net Current	1	1	1	1	1	1	1	1	1	1	1	1
Inventory Net	2	2	2	2	2	2	2	2	1	1	1	1
Prepaid Expense And Other Assets Current	1	1	0	1	1	1	1	1	0	0	0	0
Assets Current	6	6	4	6	4	5	5	5	4	5	5	6
Goodwill	1	1	1	1	1	1	1	1	1	1	1	0
Intangible Assets Net Excluding Goodwill	13	1	1	1	1	1	1	1	1	0	0	0
Property Plant And Equipment Net	2	2	2	2	2	2	2	2	2	2	1	2
Operating Lease Right Of Use Asset	3	2	2	2	2	2	2	2	2	2	2	2
Investments	0	0	0	-	-	-	-	-	-	-	-	-
Other Assets Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Assets	26	12	10	12	10	10	11	11	10	10	10	10
Liabilities And Stockhold…
Accounts Payable Current	-	-	-	-	-	-	-	2	1	1	1	1
Liabilities Current
Accrued Liabilities And Other Liabilities	0	0	0	1	1	0	0	1	0	0	0	0
Deferred Revenue	-	-	0	0	0	0	0	0	0	0	0	0
Notes Payable Current	0	0	0	0	0	0	0	0	0	0	0	0
Business Combination Contingent Consideration Liab…	-	-	-	-	-	-	0	0	0	0	0	-
Derivative Liabilities Current	-	-	-	-	0	0	-	-	-	-	-	-
Finance Lease Liability Current	-	0	0	0	0	0	0	0	0	0	-	-
Operating Lease Liability Current	1	0	0	0	0	0	0	0	0	0	0	0
Liabilities Current	14	3	3	3	2	3	2	3	3	2	3	2
Operating Lease Liability Noncurrent	3	2	2	2	1	1	2	2	2	2	2	2
Finance Lease Liability Noncurrent	-	0	0	0	0	0	0	0	0	0	-	-
Convertible Long Term Notes Payable	-	1	-	-	-	-	-	-	-	-	-	-
Long Term Notes Payable	-	0	0	1	1	1	1	1	1	1	1	0
Long Term Loans Payable	-	0	-	-	-	-	-	-	-	-	-	-
Liabilities	21	7	6	6	5	5	5	6	5	5	5	4
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	30	26	25	25	24	24	24	22	21	20	19	19
Retained Earnings Accumulated Deficit	-26	-22	-21	-20	-19	-19	-18	-17	-16	-16	-15	-14
Stockholders Equity	5	4	4	5	5	5	6	5	5	5	5	6
Minority Interest	1	0	0	0	0	0	0	0	0	0	0	1
Liabilities And Stockholders Equity	26	12	10	12	10	10	11	11	10	10	10	10
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	5	5	5	5	5	5	5	5	5	5	5	5
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	25	25	25	25	25	25	25	25	25	25	25	25
Common Stock Shares Issued	10	8	8	8	8	8	8	7	6	6	6	6
Shares Outstanding	10	8	8	8	8	8	8	7	6	6	6	6

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	3.51%	4.24%	-18.08%	-	-	-	-	-	-	-	-	-
2025	-16.30%	-3.99%	-6.88%	-18.08%	-5.54%	-9.23%	-21.78%	-10.40%	-29.70%	2.05%	-14.69%	-10.58%
2024	-5.57%	-1.56%	19.38%	7.51%	14.62%	28.06%	6.08%	16.41%	16.11%	-7.21%	-20.98%	-16.07%
2023	-	-	-	-	-	-	22.73%	32.39%	28.69%	3.74%	-2.80%	0.93%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	0.43	1.70	1.47	1.69	1.74	1.88	2.07	1.51	1.36	1.96	1.98	3.58
Quick Ratio	0.19	0.84	0.59	0.82	0.62	0.84	1.11	0.64	0.64	1.27	1.31	2.69
Working Capital	-8.27M	2.32M	1.38M	2.29M	1.77M	2.22M	2.64M	1.56M	955.00K	2.38M	2.50M	4.24M
Leverage & Debt
Debt to Equity	3.84	1.78	1.14	1.17	0.92	0.93	0.81	1.12	1.16	1.08	0.93	0.59
Interest Coverage TTM	-2.37	-48.40	-64.46	-35.89	-32.71	-33.92	-37.02	-58.70	-75.14	-119.48	-231.80	-4.00
Debt Ratio	0.79	0.61	0.53	0.52	0.48	0.47	0.45	0.53	0.54	0.50	0.48	0.37
Efficiency & Turnover
Asset Turnover TTM	0.67	1.02	1.07	1.05	1.20	0.98	0.83	0.66	0.49	0.44	0.40	0.33
Days Sales Outstanding TTM	27.71	25.73	25.66	27.11	21.23	29.71	32.90	55.67	56.67	43.13	38.16	73.55
Receivables Turnover TTM	13.17	14.19	14.22	13.46	17.19	12.29	11.10	6.56	6.44	8.46	9.56	4.96
Per Share Metrics
Diluted EPS TTM	-0.69	-0.39	-0.38	-0.35	-0.37	-0.41	-0.50	-0.57	-0.57	-0.54	-0.56	-0.46
Free Cash Flow Per Share TTM	-0.35	-0.18	-0.17	-0.26	-0.33	-0.44	-0.65	-0.60	-0.61	-0.72	-0.68	-0.68
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	35.08%	38.90%	39.48%	41.39%	40.62%	36.92%	31.63%	22.60%	14.16%	12.48%	9.15%	13.91%
Operating Profit Margin TTM	-44.77%	-31.36%	-29.35%	-25.54%	-26.06%	-33.83%	-40.91%	-58.47%	-75.02%	-73.18%	-85.03%	-86.04%
Net Profit Margin TTM	-51.26%	-28.54%	-26.27%	-23.83%	-24.21%	-30.70%	-37.76%	-55.18%	-71.31%	-68.30%	-77.97%	-75.02%
Growth Metrics
Net Revenue Growth (1Y)	3.38%	10.14%	31.46%	73.42%	133.07%	116.01%	112.47%	90.51%	74.01%	108.41%	99.66%	71.66%
Net Income Growth (1Y)	118.86%	2.39%	-8.56%	-25.11%	-20.86%	-2.91%	2.92%	40.13%	7.43%	-12.99%	-32.83%	-53.82%
EPS Growth (1Y)	85.86%	-4.59%	-24.20%	-38.28%	-35.33%	-24.03%	-10.36%	21.89%	-2.74%	-18.75%	-33.98%	-54.97%
Valuation Metrics
P/E TTM	-0.73	-1.62	-4.22	-7.00	-6.99	-7.26	-8.85	-4.57	-3.78	-5.05	-3.79	-4.57
P/B TTM	0.83	1.30	2.59	3.75	3.91	4.37	4.78	3.40	2.98	3.41	2.34	1.94
P/S TTM	0.37	0.46	1.11	1.67	1.69	2.23	3.34	2.52	2.70	3.45	2.95	3.43
Market Cap	4.52M	5.19M	12.65M	19.45M	19.75M	22.78M	29.04M	16.95M	13.51M	16.33M	12.08M	12.11M
Enterprise Value	4.13M	5.24M	13.22M	18.53M	20.00M	22.61M	28.29M	16.98M	13.57M	15.07M	9.97M	9.13M
Calculated Values
Free Cash Flow TTM	-3.12M	-1.45M	-1.34M	-2.08M	-2.52M	-3.40M	-4.24M	-3.97M	-3.82M	-4.29M	-3.85M	-3.91M
Net Debt	-390.00K	44.00K	578.00K	-921.00K	250.00K	-178.00K	-756.00K	31.00K	57.00K	-1.26M	-2.11M	-2.99M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-23Sale

Owner: Levy, Adam R.

Title: Chief Executive Officer

Shares: 5,000

Price/Share: $0.59

Value: $2,950.00

Shares Owned: 322,692

Relationship: Director,Officer

Ownership: Direct

2026-06-11Sale

Owner: Levy, Adam R.

Title: Chief Executive Officer

Shares: 3,000

Price/Share: $0.61

Value: $1,830.00

Shares Owned: 333,692

Relationship: Director,Officer

Ownership: Direct

2026-06-08Sale

Owner: Levy, Adam R.

Title: Chief Executive Officer

Shares: 3,000

Price/Share: $0.55

Value: $1,650.00

Shares Owned: 336,692

Relationship: Director,Officer

Ownership: Direct

2026-06-01Sale

Owner: Levy, Adam R.

Title: Chief Executive Officer

Shares: 2,000

Price/Share: $0.59

Value: $1,180.00

Shares Owned: 342,692

Relationship: Director,Officer

Ownership: Direct

2026-05-29Sale

Owner: Levy, Adam R.

Title: Chief Executive Officer

Shares: 3,000

Price/Share: $0.60

Value: $1,800.00

Shares Owned: 344,692

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-23	Levy, Adam R.	Director,Officer	Chief Executive Officer	Direct	Sale	5,000	0.59	$2,950.00	322,692	4
2026-06-11	Levy, Adam R.	Director,Officer	Chief Executive Officer	Direct	Sale	3,000	0.61	$1,830.00	333,692	4
2026-06-08	Levy, Adam R.	Director,Officer	Chief Executive Officer	Direct	Sale	3,000	0.55	$1,650.00	336,692	4
2026-06-01	Levy, Adam R.	Director,Officer	Chief Executive Officer	Direct	Sale	2,000	0.59	$1,180.00	342,692	4
2026-05-29	Levy, Adam R.	Director,Officer	Chief Executive Officer	Direct	Sale	3,000	0.60	$1,800.00	344,692	4
2025-12-22	Levy, Adam R.	Director,Officer	Chief Executive Officer	Direct	Sale	6,000	1.61	$9,660.00	361,692	4
2025-11-06	Levy, Adam R.	Director,Officer	Chief Executive Officer	Direct	Sale	4,000	2.52	$10,080.00	367,692	4
2025-10-03	Henry, Scott Robert	Director	-	Direct	Sale	7,175	2.55	$18,296.25	113,356	4
2025-10-03	Levy, Adam R.	Director,Officer	Chief Executive Officer	Direct	Sale	2,400	2.55	$6,120.00	371,692	4
2025-09-25	Henry, Scott Robert	Director	-	Direct	Sale	7,697	2.36	$18,164.92	121,356	4
2025-08-28	Levy, Adam R.	Director,Officer	Chief Executive Officer	Direct	Sale	4,000	2.47	$9,880.00	358,284	4
2025-06-13	Henry, Scott Robert	Director	-	Direct	Sale	3,000	2.57	$7,710.00	129,053	4
2025-06-11	Levy, Adam R.	Director,Officer	Chief Executive Officer	Direct	Sale	2,000	2.39	$4,780.00	362,284	4
2025-06-05	Levy, Adam R.	Director,Officer	Chief Executive Officer	Direct	Sale	1,000	2.32	$2,320.00	366,284	4
2025-05-30	Levy, Adam R.	Director,Officer	Chief Executive Officer	Direct	Sale	1,000	2.22	$2,220.00	368,284	4
2025-05-16	Levy, Adam R.	Director,Officer	Chief Executive Officer	Direct	Sale	1,000	2.58	$2,580.00	369,284	4
2025-05-12	Henry, Scott Robert	Director	-	Direct	Sale	3,000	2.69	$8,070.00	132,053	4
2025-04-10	Henry, Scott Robert	Director	-	Direct	Sale	3,000	2.61	$7,830.00	135,053	4
2025-04-01	Levy, Adam R.	Director,Officer	Chief Executive Officer	Direct	Sale	4,000	3.01	$12,040.00	370,284	4
2025-03-10	Henry, Scott Robert	Director	-	Direct	Sale	3,000	2.87	$8,610.00	138,053	4
2025-03-03	Levy, Adam R.	Director,Officer	Chief Executive Officer	Direct	Sale	4,000	3.16	$12,640.00	374,284	4
2025-02-10	Henry, Scott Robert	Director	-	Direct	Sale	3,000	3.27	$9,810.00	138,553	4
2025-02-03	Levy, Adam R.	Director,Officer	Chief Executive Officer	Direct	Sale	4,000	3.64	$14,560.00	378,284	4
2025-01-07	Henry, Scott Robert	Director	-	Direct	Sale	3,000	3.37	$10,110.00	141,553	4
2025-01-02	Levy, Adam R.	Director,Officer	Chief Executive Officer	Direct	Sale	4,000	3.96	$15,840.00	382,284	4
2024-12-20	Henry, Scott Robert	Director	-	Direct	Sale	3,000	4.64	$13,920.00	144,553	4
2024-11-20	Stein, John Nachum	Director	-	Direct	Purchase	3,636	2.75	$9,999.00	471,456	4
2024-11-20	Glassman, Steven Mark	Director	-	Direct	Purchase	9,090	2.75	$24,997.50	154,155	4
2024-11-20	Drapczuk, Adam E Iii	Officer	Chief Financial Officer	Indirect	Purchase	17,500	2.75	$48,125.00	74,894	4
2024-11-20	Henry, Scott Robert	Director	-	Direct	Purchase	1,818	2.75	$4,999.50	147,553	4
2024-11-20	Levy, Adam R.	Director,Officer	Chief Executive Officer	Direct	Purchase	3,636	2.75	$9,999.00	333,196	4
2024-11-20	Zeldis, Jerome B	Director	-	Direct	Purchase	3,636	2.75	$9,999.00	106,664	4
2024-08-23	Henry, Scott Robert	Director	-	Direct	Purchase	10,000	2.50	$25,000.00	145,735	4
2024-08-23	Zeldis, Jerome B	Director	-	Direct	Purchase	10,000	2.50	$25,000.00	103,028	4
2024-08-23	Drapczuk, Adam E Iii	Officer	Chief Financial Officer	Indirect	Purchase	10,000	2.50	$25,000.00	57,394	4
2024-08-23	Glassman, Steven Mark	Director	-	Direct	Purchase	10,000	2.50	$25,000.00	145,025	4
2024-08-23	Stein, John Nachum	Director	-	Direct	Purchase	10,000	2.50	$25,000.00	471,820	4
2024-03-01	Glassman, Steven Mark	Director	-	Direct	Purchase	11,848	2.11	$24,999.28	135,025	4
2024-03-01	Henry, Scott Robert	Director	-	Direct	Purchase	23,697	2.11	$50,000.67	135,735	4
2024-03-01	Drapczuk, Adam E Iii	Officer	Chief Financial Officer	Indirect	Purchase	47,394	2.11	$100,001.34	47,394	4
2023-12-22	Glassman, Steven Mark	Director	-	Direct	Purchase	3,885	2.20	$8,547.00	123,177	4
2023-09-26	Stein, John Nachum	Director	-	Direct	Purchase	2,500	1.96	$4,900.00	500,019	4
2023-09-12	Henry, Scott Robert	Director	-	Direct	Purchase	4,000	2.28	$9,120.00	105,538	4
2023-08-22	Henry, Scott Robert	Director	-	Direct	Purchase	980	1.92	$1,881.60	101,538	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

4.97%

Inst. Shares: 408,142

Shares Outstanding: 8,204,205

2025-12-31

7.68%

Inst. Shares: 602,867

Shares Outstanding: 7,854,288

2025-09-30

6.91%

Inst. Shares: 550,936

Shares Outstanding: 7,971,299

2025-06-30

9.36%

Inst. Shares: 716,398

Shares Outstanding: 7,654,348

2025-03-31

8.57%

Inst. Shares: 654,941

Shares Outstanding: 7,645,311

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	408,142	8,204,205	4.97%
2025-12-31	602,867	7,854,288	7.68%
2025-09-30	550,936	7,971,299	6.91%
2025-06-30	716,398	7,654,348	9.36%
2025-03-31	654,941	7,645,311	8.57%
2024-12-31	454,486	6,511,574	6.98%
2024-09-30	228,587	6,569,403	3.48%
2024-06-30	158,342	6,254,659	2.53%
2024-03-31	124,924	5,982,062	2.09%
2023-12-31	100,624	5,671,842	1.77%
2023-09-30	118,431	5,714,316	2.07%
2023-06-30	132,406	5,662,338	2.34%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

NEXGEL, INC. (NXGL) — SEC Financial Statements & Analysis

NEXGEL, INC. (NXGL) is a surgical & medical instruments & apparatus company, incorporated in DE. NEXGEL, INC. trades on Nasdaq as: NXGL, NXGLW. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), NEXGEL, INC. reported a 3.38% year-over-year revenue growth, a Gross Profit Margin of 35.08% (TTM), a Debt-to-Equity ratio of 3.84x, a Price-to-Sales (P/S) ratio of 0.37x (TTM), a Price-to-Book (P/B) ratio of 0.83x (TTM), at a market cap of $4.52M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 3.38%
Gross Profit Margin TTM: 35.08%
Debt To Equity: 3.84x
P/S TTM: 0.37x
P/B TTM: 0.83x
Market Cap: $4.52M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is NEXGEL, INC. in?

NEXGEL, INC. (NXGL) operates in the Surgical & Medical Instruments & Apparatus industry.

What is NXGL's market cap?

NEXGEL, INC. (NXGL) has a market capitalization of $4.52M as of 2026-06-30.

What exchange does NXGL trade on?

NEXGEL, INC. (NXGL) trades on the Nasdaq.

Where is NEXGEL, INC. incorporated?

NEXGEL, INC. is incorporated in DE.

NEXGEL, INC.

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

NEXGEL, INC. (NXGL) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Surgical & Medical Instruments & Apparatus

Wall Street's data.
Main Street's price.

NEXGEL, INC. (NXGL) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Surgical & Medical Instruments & Apparatus

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.